INTERNATIONAL PATENT: ALIVEGEN USA, INC FILES APPLICATION FOR "METHODS OF TREATING MYOSTATIN-RELATED OR ACTIVIN A-RELATED DISORDERS USING NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS"

GENEVA, Sept. 10 -- ALIVEGEN USA, INC (810 Lawrence Drive, Suite 120Thousand Oaks, CA 91320) filed a patent application (PCT/US2025/016510) for "METHODS OF TREATING MYOSTATIN-RELATED OR ACTIVIN A-RELATED DISORDERS USING NOVEL HYBRID ACTRIIB LIGAND TRAP PROTEINS" on Feb 19, 2025. With publication no. WO/2025/183964, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAN, Hq (1634 Bluebell PlWestlake Village, CA 91362), ZHOU, Xiaolan (4744 Via CanadaNewbury Park, CA 91320)

Abstract: The present disclosure describes novel hy...